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ABSTRACT 
 
Chronic Kidney Disease (CKD) has increased incidence and prevalence in developing nations. In this 
in vitro study, we evaluated the cells proliferative effects, fibronectin (FN), transforming growth factor β 
(TGF-β1), and Reactive oxygen species (ROS) - level inhibition potential of ethanol extract of detam 1 
soybean seed (EEDS) on glucose-induced kidney mesangial cells (SV40 MES 13). The cells proliferation 
assay used 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)2H-tetrazolium 
(MTS) assay. FN and TGF-β1 level were measured using ELISA assay kit and ROS level using flow cytometry. 
Level of   FN, TGF-β1 and ROS, on CKD cells model (5 mM, 10 mM glucose-induced mesangial cell) treated 
with EEDS 6.25 µg/mL were lower significantly compared to positive control,  EEDS improve cells viability 
and decrease FN, TGF-β1 and ROS level in glucose-induced kidney mesangial cells as CKD cells model. 
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INTRODUCTION  
Chronic Kidney Disease (CKD) is a condition 
when a renal injury occurs, resulting ina decreased 
of renal excretory function, thus causing an 
accumulation of waste and metabollic products. 
These products accumulations in blood and organs 
will cause various complications. CKD presents a 
therapeutic challenge because of the high 
prevalence and high cost of dialysis. CKD can be 
caused by various factors such as hypertension, 
diabetes, infection, atherosclerosis, and others. 
CKD also becomes a risk factor of cardiovascular 
disease. Patients with CKD are restricted to protein 
intake as it will prevent complication and alleviate 
uremic symptoms in CKD (Garcı´a-Sa´nchez et al., 
2010; Ranich and Velasquez, 2001).  
The filtration unit of the kidney is the 
glomerulus, a capillary network supported by 
mesangial cells and extracellular matrix (ECM). 
Increased levels of the ECM protein fibronectin 
(FN) are also present; however, its role in diabetic 
nephropathy (DN) is unknown. Kidney mesangial 
cells cultured under high glucose conditions 
provide a model system for studying the effect high 
glucose on FN and collagen IV (COL4) (Miller et al., 
2014), transforming growth factor-β (TGF-β) 
deposition (Widowati et al., 2018; Prahastuti et al., 
2019a). 
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ECM accumulation by enhancing mesangial 
cell production of COL and FN. TGF-β mediated FN 
expression in mesangial cells (Uchiyama-Tanaka et 
al., 2002). Reactive Oxygen Species (ROS) also 
underlies as a common pathogenic component and 
accelerates the kidney disease progression and 
complications (Dounousi et al., 2006; Widowati et 
al., 2018; Prahastuti et al., 2019a). Soybean seed 
showed an antioxidant effect and an antifibrotic 
effect in the remnant kidney, which resulted in the 
improvement of the renal function. Oxidative 
stress is regulated by the balance between 
prooxidant and antioxidant systems (Peng et al., 
2017; Hayata et al., 2012; Prahastuti et al., 2019b).  
Soybean seed (Glycine max L. Merr) has been 
known for its beneficial effects in health due to its 
compounds. Previous studies reported that 
soybean contains antinutritional factors (ANF) 
which include lipase inhibitors, protease 
inhibitors, amylase inhibitors, oxalic acid, phytic 
acid, glucosinolates, flavonoid, and saponin. The 
ethanol extract of soybean also known to contain 
natural compounds such as flavonoid, phenolic, 
triterpenoid, saponin, steroid, tannin, and quinon 
(Gemede and Ratta, 2014; Prahastuti et al., 2019b).  
In this study, we evaluated the potency of Glycine 
max L. Merr ethanol extract (EEDS) for CKD 
therapy by measuring the cells proliferation effect, 
FN, TGF-β1, and ROS level on glucose-induced 
kidney mesangial cells (SV40 MES 13). 
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METHODOLOGY  
Plants Extract Preparation  
Glycine max L. (soybeans) varieties of detam 
1 was collected from Unit Pengelolaan Benih 
Sumber (UPBS) Balai Penelitian Tanaman Aneka 
Kacang dan Umbi, Malang, East Java, Indonesia. 
The plants were identified by herbarium staff, 
Department of Biology, School of Life Science and 
Technology, Bandung Institute of Technology, 
Bandung, West Java, Indonesia. Soybeans seed 
were kept in drier   tunnel service and the dried 
soybean then grinded, mashed into powder. 
Extraction using 70% distilled ethanol and 
performed based on maceration method 
(Widowati et al., 2016; Widowati et al., 2017; 
Widowati et al., 2018; Hidayat et al., 2016; 
Prahastuti et al., 2019b). 
 
Glucose-induced Mesangial Cells for Viability 
Assay 
The mesangial cells (kidney/glomerulus of 
Mus musculus) (SV40 MES 13 (ATCC® CRL-1927™) 
was obtained from Aretha Medika Utama, 
Bimolecular and Biomedical Research Center, 
Bandung, West Java, Indonesia.  The cells 5x103 
cells/well were platted in 96-well plate in 200 μL 
growth medium (DMEM) (Gibco, 11995065): F12-
K Mix Nutrient (Gibco, 21127022) (with 
comparison 1:3), 5% of fetal bovine serum (FBS) 
(Gibco, 10270106), 1% of Antibiotic-Antimycotic 
(Gibco, 1772653), 0.1 % Gentamicin (Gibco, 
15750060)  and incubated at 37°C, 5% CO2 for 24 
h. Medium were discarded and added 180 μL of (5 
mM, 25 mM and 125 mM) glucose-induced 
medium and 20 μl of EEDS (6.25 µg/ml and 3.125 
µg/mL). Cells were incubated at 37°C, 5% CO2 for 
5, 10 and 15 days. Viability were measured at day 
5, 10 dan 15 using MTS (3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4 sulfophenyl 
)-2H-tetrazolium) Assay Kit (Abcam, ab197010). 
The absorbance at 490 nm using Multiskan GO 
plate reader (Thermo Scientific, 1510) for 
calculating the percentage of cell - viability 
(Widowati et al., 2018; Prahastuti et al., 2019a).  
 
Quantification of TGF-β1 Level 
The quantitative determination of TGF-β1 
level in the cell-free supernatant was performed 
using mouse TGF-β1 ELISA Kit (Elabscience, E-EL-
M0051) based on manufactured protocol. 
Concisely, 100 µL of standard, sample and blank 
solution was added into each well then incubated 
90 minutes at 37°C. The cell-free supernatant after 
treated with EEDS were served as the sample. The 
glucose-induced mesangial cell free supernatant 
without extract was used as positive control. The 
normal cell or untreated cell was used as negative 
control. Afterward, the liquid of each well was 
discarded and 100 µL Biotinylated Detection Ab 
was added then incubated for an hour at 37°C. 
Then the liquid was dumped and the plate was 
washed three times using 200 µL wash buffer. 100 
µL HRP Conjugate was added and incubated for 30 
minutes at 37°C. The liquid was dumped again and 
the plate was washed five times using 200 µL wash 
buffer. 90 µL Substrate Reagent was added and 
incubated for 15 minutes at 37°C. 50 µL Stop 
Solution was added and the absorbance was read 
at 450 nm (Widowati et al., 2018; Dai et al., 2014; 
Prahastuti et al., 2019a). 
 
Quantification of Fibronectin Level 
The quantitative determination of 
Fibronectin level in the cell-free supernatant was 
performed using mouse FN ELISA Kit (ElabScience, 
E-EL-M0506) based on manufactured protocol. 
Concisely, 100 µL of sample, standard, and blank 
solution was added into each well then sealed and 
incubated for 90 minutes at 37°C. The cell-free 
supernatant, after glucose induced mesangial cells 
and treated with EEDS was served as the sample. 
The glucose-induced mesangial cell free 
supernatant without extract was used as positive 
control. The untreated cell or normal cell was used 
as negative control. Afterward, the liquid of each 
well was discarded and 100 µL of Biotinylated 
Detection Ab was added then incubated for an hour 
at 37°C. Then the liquid was dumped and the plate 
was washed three times using 200 µL wash buffer. 
100 µL HRP Conjugate was added and incubated 
for 30 minutes at 37°C. The liquid was dumped 
again and the plate was washed five times using 
200 µL wash buffer. 90 µL Substrate Reagent was 
added and incubated for 15 minutes at 37°C. 50 µL 
Stop Solution was added and the absorbance was 
read at 450 nm (Widowati et al., 2018; Dai et al., 
2014; Pankov et al., 2004; Prahastuti et al., 2019a). 
 
Quantification of Reactive Oxygen Species 
The ROS generation of SV40 MES 13 cells 
induced with glucose were measured using the 
DCFDA – Cellular Reactive Oxygen Species 
Detection Assay Kit (Abcam, ab113851,) and flow 
cytometry. SV40 MES13 cells were suspended into 
buffer DCFDA in FACS tube at final concentration of 
250,000 cells per 500 µL. DCFDA was added to cells 
suspension at final concentration 20 µM on each 
tube. The cells was then incubated at 37°C, 5% CO2 
(dark room) for 45 minutes. Glucose 5 mM and 
10mM (Amresco, 0188) and EEDS (6.25 µg/mL and 
3.125 µg/mL) were added to each tube. The TBHP-
induced mesangial cell free supernatant without 
extract was used as positive control.                              
The  normal  cell   or  untreated  cell  was   used   as  
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negative control. Cells were incubated at 37°C, 5% 
CO2 (dark room) for 4 hours. ROS was                   
measured by flow cytometer (Gilmore et al., 2017; 
Prahastuti et al., 2019a). 
 
Effect EEDS toward Kidney Mesangial Cells 
Viability 
Statistical Analysis 
SPSS 16 (SPSS Inc., Chicago, IL, USA) was 
used for analyzing data to perform one-way 
ANOVA to verify the results of different treatments 
and Duncan post hoc and T-Test was used to 
validate significant differences for all treatments 
(p<0.05). The results are displayed as 
means±standard deviation. 
 
RESULT AND DISCUSSION 
Excessive amount of glucose in renal leads 
to an activation of many metabolic pathways which 
further leads to an increase of ROS (Yu et al., 2011). 
These activated pathways induce release of ECM 
components such as FN and TGF-β1. These 
increase of and TGF-β1 are closely linked to 
glomerulosclerosis which further lead to CKD 
(Loeffler and Wolf, 2013; Widowati et al., 2018; 
Prahastuti et al., 2019a). 
The viability of glucose-induced SV 40 MES 
13 and treated with EEDS were assessed for 5, 10, 
and 15 days of incubation. The results were shown 
in Table I, II, and III. Based on the result, the 
viability of EEDS 3.125 µg/mL and 6.25 µg/mL are 
significantly higher than positive control at some 
levels of glucose-induced and days of incubation. 
However, the viability of samples at day 15 of 
incubation showed lower viability compared to 
other incubation time. The viability of each sample 
is decreased when the incubation time is longer. 
This result was in line with previous research that 
jati belanda leaf and mangosteen peel extracts 
improved cell viability  on  glucose-induced  mouse  
Table I. Effect of EEDS towards viability of glucose-induced kidney mesangial cells at 5 days of incubation  
 
Sample  
Glucose Concentration 
0 Mm 5 mM 25 mM 125 mM 
Control 100.00±5.84%a 100.00±5.84%a 100.00±5.84%a 100.00±5.84%cd 
Positive Control  96.71±0.91%a 84.78±1.71%a 74.92±1.30%a 
EEDS 3.125 µg/mL 176.85±28.81%c 193.66±29.67%c 142.59±21.84%b 99.03±2.03%c 
EEDS 6.25 µg/mL 147.34±16.30%b 163.42±24.59%b 158.42±9.80%c 95.16±3.85%b 
*Data is served in average±standard deviation. Different superscript letters in the same column of 0 mM 
(a,b,c), 5 mM (a,b,c), 25 mM (a,b,c), 125 mM (a,b,c,cd,) glucose concentration show significant differences 
among treatments of EEDS concentrations (P<0.05) analyzed using ANOVA and Duncan post hoc test. 
 
Table II. Effect of EEDS towards viability of glucose-induced kidney mesangial cells at 10 days of incubation  
 
Concentration 
Glucose Concentration 
0 mM 5 mM 25 mM 125 mM 
Control 100.00±5.84a 100.00±5.84a 100.00±5.84bc 100.00±5.84c 
Positive Control  96.64±0.43a 86.84±1.50a 73.26±2.25a 
EEDS 3.125 µg/mL 147.24±15.42b 111.10±4.43ab 99.63±0.49b 88.70±0.66b 
EEDS 6.25 µg/mL 110.11±1.87ab 133.98±21.57b 99.07±1.62b 99.08±1.32c 
*Data is served in average±standard deviation. Different superscript letters in the same column of 0 mM 
(a,ab,), 5 mM (a,ab,b), 25 mM (a,b,bc), 125 mM (a,b,c,) glucose concentration show significant differences 
among treatments of EEDS concentrations (P<0.05) analyzed using ANOVA and Duncan post hoc test. 
 
Table III. Effect of EEDS towards kidney mesangial cells viability in glucose-induced mesangial cells at 15 
days of incubation  
 
Concentration 
Glucose Concentration 
0 mM 5 mM 25 mM 125 mM 
Control 100.00±5.84a 100.00±5.84b 100.00±5.84d 100.00±5.84d 
Positive Control  76.89±2.13a 70.94±1.80a 54.12±4.18a 
EEDS 3.125 µg/mL 110.44±11.69b 102.72±16.21b 91.44±7.35c 67.77±12.59c 
EEDS 6.25 µg/mL 117.40±8.35bc 100.62±9.04b 82.59±3.86b 63.61±6.77b 
 
*Data is served in average±standard deviation. Different superscript letters in the same column of 0 mM 
(a,b,bc,), 5 mM (a,b ), 25 mM (a,b,c,d ), 125 mM (a,b,c,d ) glucose concentration show significant differences 
among treatments of EEDS concentrations (P<0.05) analyzed using ANOVA and Duncan post hoc test. 
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kidney cells (Widowati et al., 2018; Prahastuti et 
al., 2019a) 
At 5 days of incubation, the viability of 5 mM 
glucose-induced EEDS 3.125 µg/mL was the 
highest among other samples (193.66±29.67%) 
while EEDS at concentration 6.25 µg/mL was 
lower compared to EEDS 3.125 µg/mL 
(163.42±24.59%) (Table I). Both treatments of 
EEDS (3.125; 6.25 µg/mL) were significantly 
different compared to positive control. At 10 days 
incubation, EEDS 6.25 µg/mL with 5 mM glucose-
induced had the highest viability (133.98±21.57%) 
compared to other treatments then the viability 
gradually decrease, EEDS 3.125 µg/mL also shows 
the same pattern (Table II). However, a higher level 
of glucose induction decreased mesangial cell 
viability. This pattern is also shown at 10 days 
incubation, the highest viability was EEDS 6.25 
µg/mL at 5 mM glucose induction 
(133.98±21.57%).   The highest cell viability 
(100.62±9.04%) was 15 days incubation (Table 
III), on 5 mM glucose-induced cells and treated 
with EEDS 3.125 µg/mL, the viability of the cells 
decreased at a higher level of glucose induction. 
Moreover, the viability of the cells of EEDS 
treatment was significantly different compared to 
positive control. This result was in line with the 
previous study which shows that EEDS also has 
high viability (about >90%) on 3T3-L1 cells 
(Hidayat et al., 2015). The cell viability decreased 
as the level of increased-glucose induction. The 
glucose induction can decrease the cell viability, 
induced apoptosis, and elevated level of 
intracellular reactive species in a concentration 
and time-dependent manner (Hou et al., 2015). The 
high level of cells viability indicates that the EEDS          
can protect the cell from damage of                        
glucose induction in the renal cell (Prahastuti et al., 
2019a). 
In the current study, SV40 MS13 kidney 
mesangial cells were cultured in a high 
concentration of glucose which is related to 
diabetic glomerulosclerosis condition. To study the 
effect of EEDS on CKD cells model toward, cells 
viability, FN TGF-β1, ROS level which were used as 
a parameter due to their role in glomerulosclerosis 
disease. The EEDS 6.25 µg/mL was able to reduce 
the FN level especially at 5 mM glucose induction 
as low as 3.72±0.13 ng/mL. However, the 
difference between EEDS 3.125 and 6.25 µg/mL 
treatments was not significant. At this point, it also 
indicated that higher glucose induction increased 
FN level. However, the EEDS treatment decreased 
the FN level significantly compared to positive 
control both after induced 5 mM and 10 mM of 
glucose (Figure 1). This result was in line with 
previous research that jati belanda leaf and 
mangosteen peel extracts decreased FN level on 
glucose-induced glomerulus cells (Widowati et al., 
2018; Prahastuti et al., 2019a). 
The previous study exhibited a significant 
increase of FN level in a higher level of glucose 
induction (Nahman et al., 1992). Glucose can 
increase the FN level which is key protein matrix 
 
 
Figure 1. Effect EEDS (3.125 µg/mL, 6.25 µg/mL) toward FN level on 5 mM and 10 mM glucose-induced 
kidney mesangial cells   
 
*The histogram are presented as mean ± standard deviation of negative control, positive control and EEDS 
6.25 µg/mL (A) and EEDS 3.125 µg/mL (B). Asterisk symbols (*) show significant difference between 
positive control (5 mM, 10 mM glucose induction) and EEDS 6.25µg/mL treatment, between positive control 
(5 mM, 10 mM glucose induction) and 3.125 µg/mL treatment on cells (P < 0.05) (independent T-test). 
Pound symbol (#) show significant difference between negative control and positive control (5 mM glucose 
induction), negative control and positive control (10 mM glucose induction) (P < 0.05) (independent T-test). 
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accumulation in excess in kidney disease             
(Wang et al., 2008). The accumulated level of FN on 
glucose-induced cell can be mediated by oxygen-
free radical, therefore the antioxidant can           
lower the FN accumulation. The result            
exhibited that EEDS was able to suppress the           
FN expression in hyperglycemic cell model     
(Figure 1). 
The EEDS 6.25 µg/mL and 3.125 µg/mL 
decreased TGFβ1. EEDS 6.25 µg/mL at 5 mM 
glucose-induced cells showed lowest TGFβ1   level 
(62.73 ± 10.89 pg/mL), it was the best treatment 
compared to 10 mM of glucose induction. 
TGF-β plays a crucial role in mesangial 
matrix expansion. According to previous study, the 
injured glomeruli express more TGF-β1 mRNA, 
synthesize more TGF-β1 protein, and secrete many 
fold greater amounts of FN and proteoglycans than   
normal glomeruli (Okuda et al., 1990). Thus the 
damage in glomeruli can lead to a renal disease. 
The excessive amount of TGF- β1 due to glucose 
induction can be suppressed by the the treatment 
with EEDS.  normal glomeruli (Okuda et al., 1990). 
Thus the damage in glomeruli can lead to a renal 
disease. The excessive amount of TGF- β1 due to 
glucose induction can be suppressed by the the 
treatment with EEDS. The EEDS treatment resulted 
in significant decrease of TGF-β1. This result was 
supported by previous research that jati belanda 
leaf and mangosteen peel extracts decreased TGF-
 
 
Figure 2. Effect EEDS (3.125 µg/mL, 6.25 µg/mL)   toward TGF-β1 level on 5 mM and 10 mM of glucose-
induced SV 40 MES 13  
 
* The histogram are presented as mean ± standard deviation of negative control, positive control and EEDS 
6.25 µg/mL (A) and EEDS 3.125 µg/mL (B). Asterisk symbols (*) show significant difference between 
positive control (5 mM, 10 mM glucose induction) and EEDS 6.25µg/mL treatment, between positive 
control (5 mM, 10 mM glucose induction) and 3.125 µg/mL treatment on cells (P < 0.05) (independent T-
test). Pound symbol (#) show significant difference between negative control and positive control (5 mM 
glucose induction), negative control and positive control (10 mM glucose induction) (P < 0.05) 
(independent T-test). 
 
Table IV.  Effect EEDS towad ROS level on glucose-induced mesangial cells  
 
Treatment ROS level (%) ROS level (MFI) 
Positive control (Cell + TBHP) 82.51 ± 2.83d 19.68±0.67e 
Negative control (cell + DCFDA) 6.54 ± 0.31b 10.90±0.49bc 
Glucose 5 mM 8.26 ± 1.48b 11.40±0.31c 
Glucose 10 mM 50.99 ± 3.42c 15.24±0.56d 
Glucose 5 mM + EEDS 6.25 µg/mL 4.58 ± 1.02ab 10.06 ± 0.20bc 
Glucose 10 mM + EEDS 6.25 µg/mL 2.26 ± 0.418a 10.03 ± 0.32ab 
 
*DCFDA = 2’,7’ dichlorofluorescin diacetate, MFI = mean fluorescence intensity, TBHP = tert-butyl 
hydroperoxide,  
Data are presented as mean ± standard deviation. Different superscripts in the same column (a,ab,b,c,d) 
show significantly differences among treatment in ROS level (%) and different superscript (a,ab,bc,c,d,e) 
show significantly  differences among treatment in ROS level (MFI) according to  Duncan’s post hoc test (P 
< 0.05) 
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β1 level on glucose-induced glomerulus cells  
(Widowati et al., 2018; Prahastuti et al., 2019a). 
The reduction of and TGF-β1 levels are associated 
with antioxidant activity of EEDS. Ethanol extract 
of soybean is reported to contain phenolic and 
flavonoid contents which have good potential as an 
antioxidant (Juan and Chou, 2010; Prahastuti et al., 
2019a). 
Antioxidant compounds inhibit activation 
the protein kinase c, which induce diabetic 
nephropathy and also TGF-β1 synthesis in the 
mesangial    cell   in    response     to     high     glucose 
 
 
Figure 3. Dot blot of EEDS 6.25 µg/mL on glucose-induced mesangial cell toward ROS level. This figure is 
the dot blot representative of ROS level in glucose-induced mesangial cells treated with EEDS 6.25 µg/mL 
 
*EEDS = ethanol extract of detam 1 soybean; TBHP = tert-butyl hyroperoxide; DCFDA = 2’,7’ –
dichlorofluorescin diacetate 
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induction. Inhibition of protein kinase c effectively 
blocks high glucose-, phorbol ester-, and H2O2-
induced TGF-β1 and FN synthesis (Ha et al., 1998). 
The ROS (%) level of 10 mM glucose-
induced mesangial cells was higher than   5 mM 
glucose induction, EEDS treatment (6.25 µg/mL 
and 3.125 µg/mL) decreased ROS level both 5 mM 
and 10 mM glucose induction was comparable with 
the negative control. These results indicate that the 
EEDS treatment can significantly lower the ROS 
level on CKD cells model (Table 4, Figure 1). 
Soybeans showed much higher free-radical 
scavenging activity, inhibition of lipid peroxidation 
and ability to chelate metals. Soy isoflavones as 
antioxidants have been reported to reduce the risk 
of coronary heart disease.  (Ramdath et al., 2017). 
To inhibit lipid peroxidation, to prevent low 
density-lipoprotein oxidation and to reduce 
oxidative DNA damage. Soybean also reported 
having phenolic compounds which are also a great 
antioxidant source (Han and Baik, 2008; Prahastuti 
et al., 2019a).  Antioxidants are able to improve cell 
growth and regenerate a damaged extracellular 
matrix under high glucose concentration 
(hyperglycemic) through glycation of proteins 
(Chen et al., 2012; Kurtz and Oh, 2012; Widowati et 
al., 2018; Prahastuti et al., 2019a). 
Oxidative stress is associated with other 
disease related to a reduced antioxidant defense 
which led to a decreased renal function, therefore, 
it can be said that the antioxidants might exert a 
key role to protect mesangial cells and might be 
applied therapeutically as nephroprotective agent 
as well as prevent renal scarring (Lee and Song, 
2009; Tylicki et al., 2003). The presence of 
antioxidant according to Jha et al. (2016) can ROS 
into nonreactive oxygen molecules which is 
harmless to cells (Jha et al., 2016). Also, it obstructs 
glucose absorption through inhibition of 
carbohydrate-hydrolyzing enzymes such as α-
glucosidase and α-amylase and down-regulates the 
TGF-β expression and FN level by decreasing 
NADPH oxidase expression (Widowati et al., 2018; 
Manaharan et al., 2012; Han et al., 2017; Prahastuti 
et al., 2019a). Table IV shows that EEDS is capable 
to lower ROS level mesangial cells treated with 5 
and 10 mM glucose compared to the positive 
control.  EEDS is able to reduce ROS level I due to 
antioxidant activity, therefore it might be 
considered to be a nephroprotective strategy with 
further studies.  
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